Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Samantha Semenkow's Stock Ratings
Citigroup Analyst
Samantha Semenkow is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-0.77%
Smart Score
Overall Average Return Percentile
32nd
Number of Ratings
72
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | WVE | Buy Now | WAVE Life Sciences | $16.55 | 81.21% | $16 → $30 | Maintains | Buy | Get Alert | |
| 12/09/2025 | GPCR | Buy Now | Structure Therapeutics | $67.83 | 47.44% | $60 → $100 | Maintains | Buy | Get Alert | |
| 11/26/2025 | NKTR | Buy Now | Nektar Therapeutics | $53.60 | 90.3% | → $102 | Initiates | → Buy | Get Alert | |
| 11/26/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $27.02 | 40.64% | → $38 | Initiates | → Buy | Get Alert | |
| 11/25/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.97 | 19.33% | → $136 | Initiates | → Buy | Get Alert | |
| 11/17/2025 | ARGX | Buy Now | argenx | $852.47 | 31.85% | $1041 → $1124 | Maintains | Buy | Get Alert | |
| 11/13/2025 | BHVN | Buy Now | Biohaven | $11.44 | 22.38% | $28 → $14 | Maintains | Buy | Get Alert | |
| 11/11/2025 | PRME | Buy Now | Prime Medicine | $4.15 | 2.41% | $5 → $4.25 | Maintains | Neutral | Get Alert | |
| 11/11/2025 | ROIV | Buy Now | Roivant Sciences | $22.07 | 17.78% | $25 → $26 | Maintains | Buy | Get Alert | |
| 11/07/2025 | CPRX | Buy Now | Catalyst Pharmaceuticals | $24.02 | 37.39% | $31 → $33 | Maintains | Buy | Get Alert | |
| 10/29/2025 | ROIV | Buy Now | Roivant Sciences | $22.07 | 13.25% | $16 → $25 | Maintains | Buy | Get Alert | |
| 10/29/2025 | BIOA | Buy Now | Bioage Labs | $12.75 | 17.65% | $10 → $15 | Maintains | Buy | Get Alert | |
| 10/29/2025 | MLTX | Buy Now | MoonLake | $14.51 | -65.54% | $5 → $5 | Downgrade | Neutral → Sell | Get Alert | |
| 10/22/2025 | BIOA | Buy Now | Bioage Labs | $12.75 | -21.57% | $5 → $10 | Upgrade | Neutral → Buy | Get Alert | |
| 09/30/2025 | MLTX | Buy Now | MoonLake | $14.51 | -65.54% | $72 → $5 | Downgrade | Buy → Neutral | Get Alert | |
| 09/17/2025 | BHVN | Buy Now | Biohaven | $11.44 | 144.76% | → $28 | Initiates | → Buy | Get Alert | |
| 09/02/2025 | ROIV | Buy Now | Roivant Sciences | $22.07 | -27.52% | → $16 | Initiates | → Buy | Get Alert | |
| 08/14/2025 | CABA | Buy Now | Cabaletta Bio | $2.42 | 312.37% | $13 → $10 | Maintains | Buy | Get Alert | |
| 08/12/2025 | PRME | Buy Now | Prime Medicine | $4.15 | -3.61% | $1.5 → $4 | Maintains | Neutral | Get Alert | |
| 07/16/2025 | WVE | Buy Now | WAVE Life Sciences | $16.55 | -3.35% | → $16 | Initiates | → Buy | Get Alert | |
| 05/27/2025 | PRME | Buy Now | Prime Medicine | $4.15 | -63.86% | $10 → $1.5 | Downgrade | Buy → Neutral | Get Alert | |
| 05/16/2025 | CABA | Buy Now | Cabaletta Bio | $2.42 | 436.08% | $17 → $13 | Maintains | Buy | Get Alert | |
| 05/15/2025 | ALLO | Buy Now | Allogene Therapeutics | $1.47 | 172.11% | $8 → $4 | Maintains | Buy | Get Alert | |
| 05/09/2025 | ARGX | Buy Now | argenx | $852.47 | -5.8% | $796 → $803 | Maintains | Buy | Get Alert | |
| 05/02/2025 | GPCR | Buy Now | Structure Therapeutics | $67.83 | -11.54% | → $60 | Initiates | → Buy | Get Alert | |
| 04/17/2025 | ARGX | Buy Now | argenx | $852.47 | -6.62% | $681 → $796 | Maintains | Buy | Get Alert | |
| 03/24/2025 | BIOA | Buy Now | Bioage Labs | $12.75 | -60.78% | $7 → $5 | Maintains | Neutral | Get Alert | |
| 01/07/2025 | SLRN | Buy Now | Acelyrin | — | — | $6 → $3 | Maintains | Neutral | Get Alert | |
| 12/09/2024 | BIOA | Buy Now | Bioage Labs | $12.75 | -45.1% | $45 → $7 | Downgrade | Buy → Neutral | Get Alert | |
| 12/02/2024 | VYGR | Buy Now | Voyager Therapeutics | $4.36 | 175.23% | → $12 | Initiates | → Buy | Get Alert | |
| 10/21/2024 | BIOA | Buy Now | Bioage Labs | $12.75 | 252.94% | → $45 | Initiates | → Buy | Get Alert | |
| 10/17/2024 | ARGX | Buy Now | argenx | $852.47 | -25.51% | $512 → $635 | Maintains | Buy | Get Alert | |
| 08/09/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.47 | 444.22% | $7 → $8 | Maintains | Buy | Get Alert | |
| 08/09/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $24.02 | 29.06% | $27 → $31 | Maintains | Buy | Get Alert | |
| 08/09/2024 | SANA | Buy Now | Sana Biotechnology | $5.21 | 188.18% | $8 → $15 | Maintains | Buy | Get Alert | |
| 06/03/2024 | SNSE | Buy Now | Sensei Biotherapeutics | $8.20 | -51.22% | → $4 | Reinstates | Buy → Buy | Get Alert | |
| 05/22/2024 | LRMR | Buy Now | Larimar Therapeutics | $4.08 | 243.56% | $10 → $14 | Maintains | Buy | Get Alert | |
| 05/16/2024 | PRME | Buy Now | Prime Medicine | $4.15 | 140.96% | → $10 | Upgrade | Neutral → Buy | Get Alert | |
| 05/09/2024 | EDIT | Buy Now | Editas Medicine | $2.51 | 497.61% | $16 → $15 | Maintains | Buy | Get Alert | |
| 04/08/2024 | TSVT | Buy Now | 2seventy bio | — | — | $9 → $12 | Maintains | Buy | Get Alert | |
| 04/04/2024 | CABA | Buy Now | Cabaletta Bio | $2.42 | 1137.11% | $26 → $30 | Maintains | Buy | Get Alert | |
| 03/14/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $24.02 | 12.41% | → $27 | Initiates | → Buy | Get Alert | |
| 02/29/2024 | EDIT | Buy Now | Editas Medicine | $2.51 | 537.45% | $11 → $16 | Maintains | Buy | Get Alert | |
| 02/13/2024 | LRMR | Buy Now | Larimar Therapeutics | $4.08 | 145.4% | $4.5 → $10 | Maintains | Buy | Get Alert | |
| 12/08/2023 | SLRN | Buy Now | Acelyrin | — | — | → $8 | Initiates | → Neutral | Get Alert | |
| 12/08/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.47 | 376.19% | → $7 | Initiates | → Buy | Get Alert | |
| 12/08/2023 | MLTX | Buy Now | MoonLake | $14.51 | 396.21% | → $72 | Initiates | → Buy | Get Alert | |
| 12/08/2023 | MORF | Buy Now | Morphic Holding | — | — | → $46 | Initiates | → Buy | Get Alert | |
| 12/08/2023 | PRME | Buy Now | Prime Medicine | $4.15 | 140.96% | → $10 | Initiates | → Neutral | Get Alert | |
| 11/29/2023 | ARGX | Buy Now | argenx | $852.47 | -30.67% | $610 → $591 | Maintains | Buy | Get Alert | |
| 11/17/2023 | LRMR | Buy Now | Larimar Therapeutics | $4.08 | 10.43% | → $4.5 | Upgrade | Neutral → Buy | Get Alert | |
| 10/24/2023 | EDIT | Buy Now | Editas Medicine | $2.51 | 338.25% | → $11 | Upgrade | Neutral → Buy | Get Alert | |
| 10/12/2023 | TSVT | Buy Now | 2seventy bio | — | — | → $13 | Initiates | → Buy | Get Alert | |
| 09/27/2023 | IMVT | Buy Now | Immunovant | $26.44 | 89.11% | $33 → $50 | Maintains | Buy | Get Alert | |
| 09/05/2023 | SANA | Buy Now | Sana Biotechnology | $5.21 | 53.7% | → $8 | Initiates | → Buy | Get Alert | |
| 09/05/2023 | CABA | Buy Now | Cabaletta Bio | $2.42 | 807.22% | → $22 | Initiates | → Buy | Get Alert | |
| 08/11/2023 | IMVT | Buy Now | Immunovant | $26.44 | 24.81% | $28 → $33 | Maintains | Buy | Get Alert | |
| 08/09/2023 | BEAM | Buy Now | Beam Therapeutics | $27.55 | 103.26% | $60 → $56 | Maintains | Buy | Get Alert | |
| 07/18/2023 | ARGX | Buy Now | argenx | $852.47 | -30.55% | $450 → $592 | Maintains | Buy | Get Alert | |
| 05/18/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | $1.7 → $0.75 | Maintains | Neutral | Get Alert | |
| 05/18/2023 | LRMR | Buy Now | Larimar Therapeutics | $4.08 | 10.43% | $7 → $4.5 | Maintains | Neutral | Get Alert | |
| 05/15/2023 | LRMR | Buy Now | Larimar Therapeutics | $4.08 | 71.78% | → $7 | Maintains | Neutral | Get Alert | |
| 05/11/2023 | BEAM | Buy Now | Beam Therapeutics | $27.55 | 117.78% | $62 → $60 | Maintains | Buy | Get Alert | |
| 05/03/2023 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | → $6 | Initiates | → Buy | Get Alert | |
| 04/25/2023 | IMVT | Buy Now | Immunovant | $26.44 | 5.9% | → $28 | Initiates | → Buy | Get Alert | |
| 04/25/2023 | ARGX | Buy Now | argenx | $852.47 | -47.21% | → $450 | Initiates | → Buy | Get Alert | |
| 03/16/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | $2.7 → $1.7 | Maintains | Neutral | Get Alert | |
| 02/13/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | → $2.7 | Initiates | → Neutral | Get Alert | |
| 12/13/2022 | LRMR | Buy Now | Larimar Therapeutics | $4.08 | -1.84% | → $4 | Initiates | → Neutral | Get Alert | |
| 12/13/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $8.20 | -26.83% | → $6 | Initiates | → Buy | Get Alert | |
| 12/13/2022 | EDIT | Buy Now | Editas Medicine | $2.51 | 338.25% | → $11 | Initiates | → Neutral | Get Alert | |
| 12/13/2022 | BEAM | Buy Now | Beam Therapeutics | $27.55 | 125.04% | → $62 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved